These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28454498)

  • 1. Efficacy of Citalopram on Acute Ischemic Stroke Outcome: A Randomized Clinical Trial.
    Savadi Oskouie D; Sharifipour E; Sadeghi Bazargani H; Hashemilar M; Nikanfar M; Ghazanfari Amlashi S; Abbaszade Z; Sadeghihokmabadi E; Rikhtegar R; Golzari SEJ
    Neurorehabil Neural Repair; 2017 Jul; 31(7):638-647. PubMed ID: 28454498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS).
    Kraglund KL; Mortensen JK; Damsbo AG; Modrau B; Simonsen SA; Iversen HK; Madsen M; Grove EL; Johnsen SP; Andersen G
    Stroke; 2018 Nov; 49(11):2568-2576. PubMed ID: 30355209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TALOS: a multicenter, randomized, double-blind, placebo-controlled trial to test the effects of citalopram in patients with acute stroke.
    Kraglund KL; Mortensen JK; Grove EL; Johnsen SP; Andersen G
    Int J Stroke; 2015 Aug; 10(6):985-7. PubMed ID: 25854537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial.
    Robinson RG; Jorge RE; Moser DJ; Acion L; Solodkin A; Small SL; Fonzetti P; Hegel M; Arndt S
    JAMA; 2008 May; 299(20):2391-400. PubMed ID: 18505948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy comparison of citalopram, fluoxetine, and placebo on motor recovery after ischemic stroke: a double-blind placebo-controlled randomized controlled trial.
    Asadollahi M; Ramezani M; Khanmoradi Z; Karimialavijeh E
    Clin Rehabil; 2018 Aug; 32(8):1069-1075. PubMed ID: 29783900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
    Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
    Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind study.
    Kraglund KL; Mortensen JK; Johnsen SP; Andersen G; Grove EL
    Sci Rep; 2019 Dec; 9(1):20048. PubMed ID: 31882732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration.
    Hankey GJ; Hackett ML; Almeida OP; Flicker L; Mead GE; Dennis MS; Etherton-Beer C; Ford AH; Billot L; Jan S; Lung T; Lundström E; Sunnerhagen KS; Anderson CS; Thang-Nguyen H; Gommans J; Yi Q;
    Stroke; 2021 Aug; 52(8):2502-2509. PubMed ID: 34015940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Charney DA; Heath LM; Zikos E; Palacios-Boix J; Gill KJ
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1756-65. PubMed ID: 26208048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke: Results From EFFECTS, a Randomized Controlled Trial.
    Lundström E; Isaksson E; Greilert Norin N; Näsman P; Wester P; Mårtensson B; Norrving B; Wallén H; Borg J; Hankey GJ; Hackett ML; Mead GE; Dennis MS; Sunnerhagen KS
    Stroke; 2021 Oct; 52(10):3082-3087. PubMed ID: 34465201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effıcacy of cıtalopram on stroke recurrence: A randomızed clınıcal trıal.
    Ece Çetin F; Kumral E; Saffet Gönül A; Nezih Özdemir H; Orman M
    J Clin Neurosci; 2022 Jul; 101():168-174. PubMed ID: 35597066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.
    Porsteinsson AP; Drye LT; Pollock BG; Devanand DP; Frangakis C; Ismail Z; Marano C; Meinert CL; Mintzer JE; Munro CA; Pelton G; Rabins PV; Rosenberg PB; Schneider LS; Shade DM; Weintraub D; Yesavage J; Lyketsos CG;
    JAMA; 2014 Feb; 311(7):682-91. PubMed ID: 24549548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial.
    EFFECTS Trial Collaboration
    Lancet Neurol; 2020 Aug; 19(8):661-669. PubMed ID: 32702335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter gene polymorphisms may be associated with poststroke neurological recovery after escitalopram use.
    Lee EJ; Oh MS; Kim JS; Chang DI; Park JH; Cha JK; Heo JH; Sohn SI; Kim DE; Kim HY; Kim J; Seo WK; Lee J; Park SW; Kim YJ; Lee BC;
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):271-276. PubMed ID: 29030421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.
    AFFINITY Trial Collaboration
    Lancet Neurol; 2020 Aug; 19(8):651-660. PubMed ID: 32702334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study.
    Safarinejad MR; Hosseini SY
    Int J Impot Res; 2006; 18(2):164-9. PubMed ID: 16107866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram.
    Andersen G; Vestergaard K; Lauritzen L
    Stroke; 1994 Jun; 25(6):1099-104. PubMed ID: 8202964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effectiveness of Melissa Officinalis L. versus Citalopram on Quality of Life of Menopausal Women with Sleep Disorder: A Randomized Double-Blind Clinical Trial.
    Shirazi M; Jalalian MN; Abed M; Ghaemi M
    Rev Bras Ginecol Obstet; 2021 Feb; 43(2):126-130. PubMed ID: 33465795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.